Data gathered: April 21
Alternative Data for Terns Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 94 | Sign up | Sign up | Sign up |
| Webpage traffic | 4,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 27 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,902 | Sign up | Sign up | Sign up |
| Twitter Followers | 272 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 63 | Sign up | Sign up | Sign up |
About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity.
| Price | $2.80 |
| Target Price | Sign up |
| Volume | 961,180 |
| Market Cap | $210M |
| Year Range | $2 - $11.23 |
| Dividend Yield | 0% |
| Analyst Rating | 75% buy |
| Industry | Biotechnology |
In the news
 |
LPL Financial LLC Acquires 201,575 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN)April 18 - ETF Daily News |
|
Russell Investments Group Ltd. Trims Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)April 17 - ETF Daily News |
|
ExodusPoint Capital Management LP Lowers Stock Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)April 15 - ETF Daily News |
|
Orion Portfolio Solutions LLC Acquires Shares of 22,211 Terns Pharmaceuticals, Inc. (NASDAQ:TERN)April 12 - ETF Daily News |
|
American Century Companies Inc. Purchases 28,330 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN)April 12 - ETF Daily News |
|
Norges Bank Purchases New Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)April 10 - ETF Daily News |
Insider Transactions View All
| Kuriakose Emil filed to sell 53,317 shares at $2.5. April 2 '25 |
| Vignola Mark J. filed to sell 74,752 shares at $5.8. January 6 '25 |
| Quigley Jill M. filed to sell 8,760 shares at $5.7. January 6 '25 |
| Vignola Mark J. filed to sell 83,811 shares at $5.7. January 6 '25 |
Similar companies
Read more about Terns Pharmaceuticals (TERN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Terns Pharmaceuticals?
The Market Cap of Terns Pharmaceuticals is $210M.
What is the current stock price of Terns Pharmaceuticals?
Currently, the price of one share of Terns Pharmaceuticals stock is $2.80.
How can I analyze the TERN stock price chart for investment decisions?
The TERN stock price chart above provides a comprehensive visual representation of Terns Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Terns Pharmaceuticals shares. Our platform offers an up-to-date TERN stock price chart, along with technical data analysis and alternative data insights.
Does TERN offer dividends to its shareholders?
As of our latest update, Terns Pharmaceuticals (TERN) does not offer dividends to its shareholders. Investors interested in Terns Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Terns Pharmaceuticals?
Some of the similar stocks of Terns Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.